NCI Advisory Boards, Committees, and Review Groups

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
NCAB June 2015

Joint meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board, June 2015.

Credit: National Cancer Institute

As the federal government’s lead agency for cancer research, NCI relies on advisory committees to provide objective and expert advice on coordination of the National Cancer Program, NCI scientific priorities, development of major extramural program initiatives, future direction of NCI’s intramural and clinical trials programs, and the Frederick National Laboratory for Cancer Research.

These advisory committees are formal bodies that are established under the Federal Advisory Committee Act (FACA) of 1972. The membership and activities of these advisory bodies are coordinated by NCI’s Division of Extramural Activities.

List of Advisory Boards and Groups

  • President's Cancer Panel

    Monitors the development and execution of the activities of the National Cancer Program.

  • National Cancer Advisory Board

    Advises and assists the NCI Director on the activities of the National Cancer Program, including the review (second level) of grants and cooperative agreements for research and training.

  • Board of Scientific Advisors

    Advises and makes recommendations on research priorities conducted or supported by NCI, including the evaluation of NCI awarded grants, cooperative agreements, and contracts and concept review of activities it considers meritorious and consistent with the Institute's programs.

  • Board of Scientific Counselors - Basic Sciences

    Reviews and evaluates basic science research programs being conducted at the NCI Center for Cancer Research (CCR), including evaluation of the performance and productivity of tenured and tenure-track principal investigators, senior scientists, and senior clinicians through periodic site visits to CCR laboratories and programs.

  • Board of Scientific Counselors – Clinical Sciences and Epidemiology

    Reviews and evaluates NCI’s intramural research programs in clinical sciences and epidemiology, including evaluation of the performance and productivity of tenured and tenure-track principal investigators, senior scientists, and senior clinicians in NCI’s Center for Cancer Research and Division of Cancer Epidemiology and Genetics.

  • Clinical Trials and Translational Research Advisory Committee

    Makes recommendations on the NCI-supported national clinical trials enterprise to build a strong scientific infrastructure by bringing together a broadly developed and engaged coalition of stakeholders involved in the clinical trials process.

  • NCI Council of Research Advocates

    Provides the NCI Director with informed, non-scientific perspectives relevant to promoting research outcomes that are in the best interest of cancer patients.

  • Frederick National Laboratory Advisory Committee to the National Cancer Institute

    Reviews the state of research at the Frederick National Laboratory for Cancer Research (FNLCR) and makes recommendations to the NCI Director and the FNLCR Associate Director on the optimal use of the laboratory to meet the most urgent needs of the Institute.

  • Initial Review Groups

    Advise and make recommendations on the scientific and technical merit of applications for grants-in-aid for research, research training, research-related grants and cooperative agreements, and contract proposals for projects in the areas of cancer causation, diagnosis, treatment, and prevention.

  • Special Emphasis Panel

    Provides concept review of proposed contract or grant solicitations and reviews grant and cooperative agreement applications and contract proposals for research projects and for research and training activities in broad areas of basic and clinical cancer research.

  • Office of Federal Advisory Committee Policy

    Develops policies and provides guidance and resources to the public, advisory committee members, Congress, the President, and those managing federal advisory committees at the National Institutes of Health, Department of Health and Human Services, and other federal agencies.